| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000036691 |
| Receipt No. | R000041812 |
| Scientific Title | Foods high in melinjo resveratrol in the treatment of mild periodontitis patients |
| Date of disclosure of the study information | 2019/05/09 |
| Last modified on | 2019/05/09 (Ver. 2) |
| Basic information | ||
| Public title | Foods high in melinjo resveratrol in the treatment of mild periodontitis patients | |
| Acronym | Foods high in melinjo resveratrol in the treatment of mild periodontitis patients | |
| Scientific Title | Foods high in melinjo resveratrol in the treatment of mild periodontitis patients | |
| Scientific Title:Acronym | Foods high in melinjo resveratrol in the treatment of mild periodontitis patients | |
| Region |
|
|
| Condition | ||
| Condition | Periodontitis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The main purpose of the study is to evaluate the effect of melinjo resveratrol on not treated mild periodontitis patients. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The following clinical parameters are recorded at each visit (baseline, week2, week4): (1) pocket depth(PD); (2) clinical attachment level (CAL); (3) bleeding on probing (BOP) |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Patients will receive 150mg of melinjo resveratrol for 4 weeks. | |
| Interventions/Control_2 | Patients will receive 150mg of placebo for 4 weeks. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Mild periodontitis patients;(2) Never had a periodontitis treatment before; (3) Non-smoker; (4)Bleeding on probing 10-30%; (5) no use of systemic antibiotics or oral anti-microbial agents within the past six months; | |||
| Key exclusion criteria | (1)severe systemic disease; (2) pregnancy. | |||
| Target sample size | 60 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Tokyo Medical and Dental University | ||||||
| Division name | Department of Periodontology | ||||||
| Zip code | 113-8510 | ||||||
| Address | Yushima 1-5-45 Bunkyo tokyo JAPAN | ||||||
| TEL | 03-5803-5488 | ||||||
| iwata.peri@tmd.ac.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Tokyo Medical and Dental University | ||||||
| Division name | Department of Periodontology | ||||||
| Zip code | 113-8510 | ||||||
| Address | Yushima 1-5-45 Bunkyo tokyo JAPAN | ||||||
| TEL | 03-5803-5488 | ||||||
| Homepage URL | |||||||
| ikeda.peri@tmd.ac.jp | |||||||
| Sponsor | |
| Institute | Tokyo Medical and Dental University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | HOSODA SHC CO. LTD. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Tokyo Medical and Dental University |
| Address | Yushima 1-5-45 Bunkyo tokyo JAPAN |
| Tel | 03-5803-5488 |
| ikeda.peri@tmd.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東京医科歯科大学歯学部附属病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041812 |